Intrathecal Pump Timing for CSF-Synchronized Drug Dispersion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing implantable medical infusion pumps for intrathecal drug delivery do not effectively optimize medicament dispersion based on patient activity, leading to inefficiencies in therapeutic delivery.

Innovation Solution

An intrathecal drug delivery system that utilizes physiological sensors to monitor patient activity and synchronize medicament delivery with increased cerebrospinal fluid oscillations, defined by heart rate and respiratory patterns, to enhance medicament dispersion within the intrathecal space.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If medicament is delivered continuously or periodically according to programmed parameters, then reliable therapeutic delivery is achieved, but medicament dispersion efficiency is suboptimal

Engineering Contradiction:
Improvemedicament dispersion efficiencyVSAvoiddelivery system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system incorporates physiological sensors that continuously monitor patient activity levels and feed this information back to the pump controller. The controller adjusts medicament delivery timing and dosage based on real-time feedback from sensors detecting motion, posture changes, and respiratory patterns, thereby optimizing dispersion without requiring complex manual programming

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The delivery system automatically adapts to patient needs by using onboard sensors to detect physiological states and self-adjust delivery parameters. The system serves itself by autonomously determining optimal delivery moments based on detected CSF flow conditions, eliminating the need for external clinician intervention for routine adjustments

Inventive Principle:
Principle #25Self-service

2Productivity

If medicament delivery is synchronized with patient activity and CSF oscillations, then medicament dispersion is enhanced, but device complexity increases due to additional sensors and control mechanisms

Engineering Contradiction:
Improvemedicament dispersion efficiencyVSAvoidsensor and control system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The physiological sensors serve multiple functions: detecting patient activity levels, determining posture, monitoring respiratory patterns, and inferring CSF flow conditions. This multi-functionality reduces the need for separate specialized sensors for each parameter, thereby limiting the increase in device complexity while achieving enhanced dispersion through activity synchronization

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If fixed dosage and timing parameters are used, then device operation is simple, but therapeutic effectiveness varies with patient activity levels

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoiddelivery parameter adjustment
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system transitions from static fixed dosage parameters to dynamic adjustable parameters that automatically adapt to changing patient conditions. The pump controller continuously modifies delivery timing and dosage amounts based on real-time physiological data, ensuring consistent therapeutic effectiveness across varying activity levels without requiring manual reprogramming by clinicians or patients

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP3586893B1Optimized intrathecal drug delivery
Publication Date: 2025.11.05 MEDTRONIC INC
  • EP3586893B1 patent drawingFigure 1
  • EP3586893B1 patent drawingFigure 2
  • EP3586893B1 patent drawingFigure 3

AI summary

An intrathecal drug delivery system configured to monitor one or more physiological conditions of the patient to look for opportunities to time medicament delivery to coincide with patient activity inferring heightened cerebrospinal fluid oscillations, thereby improving dispersion of the medicament within the intrathecal space of the patient. The intrathecal drug delivery system includes an implantable medical pump, one or more physiological sensors, and an external programmer configured to program the implantable medical pump with a treatment protocol specifying at least one period of time during which a specified quantity of medicament is to be administered during which the implantable medical pump utilizes data from the one or more physiological sensors to time delivery of the medicament.